Global Initiative for Chronic Obstructive Lung Disease

The latest 2017 COPD GOLD guidelines address advancements in COPD management and
incorporate evidence from recent landmark clinical trials. There are a number of important changes:

•  Severity of airflow obstruction via spirometry is no longer part of the severity classification system. 
• Dual bronchodilatation with LABA/LAMA therapy is recommended for GOLD grades B and C.
•  Inhaled corticosteroids should no longer be used as monotherapy in COPD.
•  Pharmacotherapy for secondary pulmonary hypertension in the setting of COPD is not recommended. 
• Oxygen therapy is also not recommended for COPD patients with no evidence of severe resting hypoxaemia.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic

Obstructive Lung Disease 2017 Report.